A nurse on a pediatric clinic is collecting data from a school-age child and their parent. Which of the following findings should the nurse identify as an indication of potential maltreatment?

Ferrous sulfate is commonly prescribed during pregnancy to prevent or treat iron deficiency anemia caused by increased maternal blood volume and fetal iron demands. Although effective, oral iron supplements frequently produce gastrointestinal adverse effects that can affect adherence to therapy. Nurses should educate clients about expected side effects and monitor for complications that may require intervention. Recognizing common versus abnormal effects helps promote safe use and appropriate reporting.

Rationale:
A. Dry mouth is not a common adverse effect of ferrous sulfate therapy. Iron supplements primarily affect the gastrointestinal tract, leading to symptoms such as constipation, nausea, abdominal discomfort, and dark stools. Dry mouth is more commonly associated with medications that have anticholinergic properties rather than oral iron therapy.

B. Tinnitus is not an expected adverse effect of iron supplementation and is more commonly associated with medications such as salicylates or ototoxic drugs. Ferrous sulfate does not typically affect the auditory system. If tinnitus occurs, the nurse should consider other causes rather than attributing it to routine iron therapy.

C. Hematuria is not a common side effect of ferrous sulfate and may indicate urinary tract pathology such as infection, trauma, or renal disease. Iron supplements may darken the stool but should not cause blood in the urine. This finding would require further evaluation for causes unrelated to routine supplementation.

D. Constipation is a common adverse effect of ferrous sulfate because iron slows gastrointestinal motility and can make stools harder to pass. Pregnant clients are already at increased risk due to hormonal changes and decreased bowel motility, making this effect more significant. The nurse should monitor bowel patterns, encourage fluids and fiber intake, and report persistent constipation that affects comfort or adherence.

Erythema toxicum neonatorum is a common, benign newborn rash that typically appears within the first 24 to 72 hours of life. It presents as erythematous macules, papules, and sometimes pustules that can appear anywhere on the body, most commonly the trunk and proximal extremities. The condition is self-limiting and resolves without treatment. Recognizing its characteristic appearance helps differentiate it from infectious or pathological neonatal skin conditions.

Rationale:
A. The first image shows diffuse erythematous macules and papules on the newborn’s trunk, which is characteristic of erythema toxicum neonatorum. The lesions may appear blotchy and can include small pustules on a red base. This benign condition is common in healthy term newborns and typically resolves spontaneously within days without intervention.

B. The second image shows milia tiny, harmless white or yellowish bumps (cysts) that form under the skin when dead skin cells or keratin get trapped. They are very common in newborns but can also appear in children and adults, usually on the face, nose, eyelids, or cheeks. They are not erythema toxicum and typically resolve on their own without treatment.

C. The third image shows erythema localized to the diaper area, which is more consistent with diaper dermatitis or irritation rather than erythema toxicum neonatorum. Diaper rash is usually confined to areas exposed to moisture and friction and does not present with scattered pustules on the trunk. This is a localized irritant condition rather than a generalized neonatal rash.

D. The fourth image shows a newborn with a flushed facial appearance, which may be related to normal physiologic changes, mild jaundice, or transient newborn coloration. It does not demonstrate the characteristic papules or pustules of erythema toxicum. The distribution and lesion type are not consistent with this benign neonatal rash.